Since our researchers developed the first single-dose, daily HIV tablet in 2006, Gilead has been at the forefront of helping transform #HIV from a serious disease to one that can be effectively treated and prevented. Read more about our work: gilead.inc/4k2R60G.
pic.x.com/Q5oeFkEtsB